Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATRI Atrion	$459.92	$459.06	$274.98 ▼ $503.24	$809.46M	0.69	23,283 shs	N/A
KIDS OrthoPediatrics	$23.27 +5.6%	$23.03	$20.25 ▼ $35.99	$535.29M	1.09	196,186 shs	221,990 shs
LGV Longview Acquisition Corp. II	$10.09	$10.09	$9.68 ▼ $10.15	N/A	N/A	N/A	N/A
NVRO Nevro	$5.85 +0.1%	$5.83	$3.17 ▼ $11.65	$224.32M	0.81	759,546 shs	753,602 shs

10 Stocks Set to Soar in Spring 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATRI Atrion	0.00%	0.00%	0.00%	0.00%	+3.27%
KIDS OrthoPediatrics	+5.58%	+10.39%	+9.97%	-3.48%	-25.15%
LGV Longview Acquisition Corp. II	0.00%	0.00%	0.00%	0.00%	0.00%
NVRO Nevro	0.00%	0.00%	0.00%	+2.20%	-40.29%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ATRI Atrion	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	4.4763 of 5 stars	4.4	1.0	0.0	3.9	1.9	4.2	0.6
LGV Longview Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NVRO Nevro	0.1971 of 5 stars	1.0	0.0	0.0	0.0	0.6	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATRI Atrion	0.00	N/A	N/A	N/A
KIDS OrthoPediatrics	2.83	Moderate Buy	$35.83	53.99% Upside
LGV Longview Acquisition Corp. II	0.00	N/A	N/A	N/A
NVRO Nevro	1.92	Reduce	$5.36	-8.29% Downside

Current Analyst Ratings Breakdown

Latest KIDS, LGV, ATRI, and NVRO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/8/2025	KIDS OrthoPediatrics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$40.00 ➝ $30.00
5/8/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/11/2025	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$26.00 ➝ $24.00
4/9/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/7/2025	KIDS OrthoPediatrics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$37.00
3/5/2025	KIDS OrthoPediatrics	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$40.00 ➝ $32.00
3/5/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00

(Data available from 5/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATRI Atrion	$181.60M	4.46	$19.68 per share	23.37	$138.02 per share	3.33
KIDS OrthoPediatrics	$212.45M	2.66	N/A	N/A	$16.14 per share	1.44
LGV Longview Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A	N/A
NVRO Nevro	$408.52M	0.55	N/A	N/A	$8.10 per share	0.72

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATRI Atrion	$19.41M	$10.64	43.23	∞	N/A	10.60%	7.75%	7.12%	N/A
KIDS OrthoPediatrics	-$20.97M	-$1.75	N/A	N/A	N/A	-15.00%	-5.78%	-4.80%	N/A
LGV Longview Acquisition Corp. II	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
NVRO Nevro	-$92.21M	-$3.05	N/A	N/A	N/A	-16.54%	-23.52%	-10.83%	N/A

Latest KIDS, LGV, ATRI, and NVRO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.26	-$0.39	-$0.13	-$0.46	$51.68 million	$52.41 million
3/4/2025	Q4 2024	KIDS OrthoPediatrics	-$0.33	-$0.29	+$0.04	-$0.69	$51.16 million	$52.67 million
3/4/2025	Q4 2024	NVRO Nevro	-$0.79	-$0.64	+$0.15	-$1.41	$102.61 million	$105.55 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATRI Atrion	$8.80	1.91%	+9.65%	82.71%	21 Years
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
LGV Longview Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A
NVRO Nevro	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATRI Atrion	N/A	9.18	3.06
KIDS OrthoPediatrics	0.19	7.17	3.68
LGV Longview Acquisition Corp. II	N/A	N/A	N/A
NVRO Nevro	0.67	5.02	3.76

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATRI Atrion	66.19%
KIDS OrthoPediatrics	69.05%
LGV Longview Acquisition Corp. II	N/A
NVRO Nevro	95.52%

Insider Ownership

Company	Insider Ownership
ATRI Atrion	22.82%
KIDS OrthoPediatrics	32.70%
LGV Longview Acquisition Corp. II	26.35%
NVRO Nevro	3.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATRI Atrion	720	1.76 million	1.36 million	Not Optionable
KIDS OrthoPediatrics	200	24.29 million	16.52 million	Optionable
LGV Longview Acquisition Corp. II	3	N/A	N/A	Not Optionable
NVRO Nevro	1,090	38.37 million	36.27 million	Optionable

KIDS, LGV, ATRI, and NVRO Headlines

Recent News About These Companies

Nevro (NVRO) Projected to Post Earnings on Tuesday

May 5, 2025 | americanbankingnews.com

Nevro Corp. Data Breach - Levi & Korsinsky, LLP Launches Investigation

April 22, 2025 | accessnewswire.com

INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Nevro Corp. Data Breach

April 21, 2025 | accessnewswire.com

Nevro Corp. Data Breach under Investigation by Levi & Korsinsky, LLP

April 21, 2025 | accessnewswire.com

Nevro Corp. Data Breach - Levi & Korsinsky, LLP Launches Investigation

April 18, 2025 | accessnewswire.com

Nevro Corp. Data Breach - Levi & Korsinsky, LLP Launches Investigation

April 17, 2025 | accessnewswire.com

Nevro Corp. Data Breach Under Investigation by Levi & Korsinsky, LLP

April 16, 2025 | accessnewswire.com

INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Nevro Corp. Data Breach

April 15, 2025 | accessnewswire.com

Levi & Korsinsky, LLP Investigates Nevro Corp. Data Breach

April 14, 2025 | accessnewswire.com

Levi & Korsinsky, LLP Investigates Nevro Corp. Data Breach

April 14, 2025 | accessnewswire.com

INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Nevro Corp. Data Breach

April 11, 2025 | accessnewswire.com

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Nevro Corp. Customers Whose Data May Have Been Compromised

April 10, 2025 | globenewswire.com

INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Nevro Corp. Data Breach

April 10, 2025 | accessnewswire.com

Nevro Corp. Data Breach - Levi & Korsinsky, LLP Launches Investigation

April 9, 2025 | accessnewswire.com

INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Nevro Corp. Data Breach

April 8, 2025 | accessnewswire.com

Nevro Files Notice of Data Breach Affecting Confidential Consumer Information

April 5, 2025 | jdsupra.com

Nevro Corp. Investigated by Federman & Sherwood for Data Breach

April 3, 2025 | globenewswire.com

Why Is Nevro (NVRO) Up 0.9% Since Last Earnings Report?

April 3, 2025 | zacks.com

Globus Medical Completes Acquisition of Nevro Corp.

April 3, 2025 | tipranks.com

Nevro Corp Completes Merger and Delists from NYSE

April 3, 2025 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

KIDS, LGV, ATRI, and NVRO Company Descriptions

Atrion NASDAQ:ATRI

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

OrthoPediatrics NASDAQ:KIDS

$23.27 +1.23 (+5.58%)

Closing price 05/12/2025 04:00 PM Eastern

Extended Trading

$23.28 +0.00 (+0.02%)

As of 04:13 AM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Longview Acquisition Corp. II NYSE:LGV

Longview Acquisition Corp. II does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on businesses in the healthcare, industrials, consumer, media, technology, and technology services sector. The company was incorporated in 2020 and is based in New York, New York.

Nevro NYSE:NVRO

$5.85 +0.01 (+0.10%)

Closing price 04/2/2025

Extended Trading

$5.85 0.00 (0.00%)

As of 04/2/2025 07:56 PM Eastern

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time